{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:34:37Z","timestamp":1773491677792,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.acuro.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:21:07Z","timestamp":1559222467000},"page":"445-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Validaci\u00f3n de las tablas del grupo CUETO para predecir la recurrencia y progresi\u00f3n del carcinoma urotelial de vejiga T1G3"],"prefix":"10.1016","volume":"43","author":[{"given":"W.","family":"Krajewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Rodr\u00edguez-Faba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Poletajew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tukiendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zdrojowy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ko\u0142odziej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Palou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2019.02.006_bib0090","first-page":"7","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acuro.2019.02.006_bib0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0105","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: The CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.urology.2013.04.007","article-title":"Predicting recurrence and progression in Chinese patients with nonmuscle-invasive bladder cancer using EORTC and CUETO scoring models","volume":"82","author":"Xu","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2019.02.006_bib0115","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/iju.12572","volume":"21","author":"Kohjimoto","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4111\/kju.2014.55.10.643","article-title":"Predicting recurrence and progression of non-muscle-invasive bladder cancer in Korean patients: a comparison of the EORTC and CUETO models","volume":"55","author":"Choi","year":"2014","journal-title":"Korean J Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0125","series-title":"Histological typing of urinary bladder tumors. En: International classification of tumors n.\u00b0 10","author":"Mostofi","year":"1973"},{"key":"10.1016\/j.acuro.2019.02.006_bib0130","series-title":"Wittekind Ch (eds) TNM classification of malignant tumours","article-title":"Urological tumours: bladder. En: WileyLiss, ed. Sobin LH","author":"Gospodarowicz","year":"2002"},{"key":"10.1016\/j.acuro.2019.02.006_bib0135","author":"Team","year":"2017","journal-title":"A language and environment for statistical computing"},{"key":"10.1016\/j.acuro.2019.02.006_bib0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2014.06.040","article-title":"Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Gu\u00e9rin: Results of a retrospective multicenter study of 2451 patients","volume":"67","author":"Gontero","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC Nomograms and Risk Groups for Predicting Recurrence Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: A systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.eururo.2013.10.001","article-title":"International variations in bladder cancer incidence and mortality","volume":"66","author":"Chavan","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00345-016-1856-9","article-title":"Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Gu\u00e9rin immunotherapy?","volume":"35","author":"Golabek","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.acuro.2019.02.006_bib0165","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bjc.2013.372","article-title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","volume":"109","author":"Xylinas","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.acuro.2019.02.006_bib0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jjco\/hyn006","article-title":"Comparison of time trends in bladder cancer incidence (1973-1997) in East Asia Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII","volume":"38","author":"Matsuda","year":"2008","journal-title":"Jpn J Clin Oncol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021048061930066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021048061930066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:35:45Z","timestamp":1759322145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021048061930066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S021048061930066X"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2019.02.006","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validaci\u00f3n de las tablas del grupo CUETO para predecir la recurrencia y progresi\u00f3n del carcinoma urotelial de vejiga T1G3","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}